Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VaReFi: Validity and Reliability of SI Joint Blocking
NCT01874236Phase 4Terminated
- Sponsor
- SI-BONE
- Start
- Apr 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in sacroiliac joint dysfunction (3 arms), sponsored by SI-BONE. Primary endpoint: Numeric Rating Scale at 1 month. Started Apr 2013; status: terminated.
02
Drugs
bupivacaine
03
Conditions
sacroiliac joint dysfunction
Beyond the preview
Go deeper on NCT01874236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01874236.